Skandinaviska Enskilda Banken Ab (Publ) Immunic, Inc. Call Options Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $24.3 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IMUX
# of Institutions
66Shares Held
47.5MCall Options Held
100KPut Options Held
60.6K-
Abrdn PLC8.24MShares$6.18 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA7.65MShares$5.74 Million0.21% of portfolio
-
Avidity Partners Management LP Dallas, TX4.7MShares$3.52 Million2.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.35MShares$3.26 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.1MShares$2.33 Million0.0% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $22.9M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...